apogene GmbH & Co.KG

Company

    • Company type:
      • Manufacturer
    • Year founded:
    • 2000
    • Employees (at the site):
    • 3
    • Turnover range:
    • <5m EUR
    • Products/services:
    • Tissue Engineering / Cell Culture, Knock Out, Xenotransplantation

    • Core competencies:
    • apoGene is focused on the field of xenotransplantation. Rabbits and pigs are genetically modified (transfer, knock out and recombination of endogenous genes) for influencing the different steps of the rejection process after xenotransplantation of animals tissues and organs. We are also investigating the expression of endogenous retroviral sequences after xenogenetic transfer. For the development of knock out animals we have developed and patented an alternative strategy, the so called screen-out of hemozygote carriers of functional defects in natural or mutagenized populations. The technique will also be very interesting for the establishment of animal models for basic and applied research.

    • Language skills:
    • English
      German
    • Key Tech / section:
      • Biotechnology: Agrobiotechnology for animals
      • Biotechnology: Analytics and separation technology
    • Industries NACE:
      • 21.20: Manufacture of pharmaceutical preparations
      • 32.50: Manufacture of medical and dental instruments and supplies
      • 21.2: Manufacture of pharmaceutical preparations
      • 72.11: Research and experimental development on biotechnology
      • 72.19: Other research and experimental development on natural sciences and engineering
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Prof. Dr. D Gottfried Brem (Mr.)
      - Management